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Abstract High frequencies of both thalassemia trait (5.2%) and
glucose 6-phosphate dehydrogenase (G6PD) deficiency for only
males (1.3%) have been observed in the Calabrian population.
The G6PD activity measurement was carried out on 1239
samples of whole blood from Calabrian subjects of both sexes
(age range 10^55) by a differential pH-metry technique which
was quite suitable to determine the G6PD deficiency in mass
screenings. The analyzed subjects showed: only the thalassemia
trait ; or only the G6PD deficiency; or only the total iron serum
deficiency; or G6PD deficiency associated with the thalassemia
trait or with the total iron serum deficiency. The G6PD
heterozygous subjects have an enzymatic activity which is
masked by both the thalassemia trait and the total iron serum
deficiency. In a population showing high frequencies of both
thalassemia trait and G6PD deficiency, the comparison of G6PD
activity of heterozygous subjects also affected with the thalasse-
mia trait is more reliable if referred to the enzymatic activity of
the carriers of the latter inherited anomaly rather than to G6PD
activity of normal subjects.
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1. Introduction
High frequencies of glucose 6-phosphate dehydrogenase
(G6PD, EC 1.1.1.49; locus linked to the X chromosome) de-
¢ciency and thalassemia (a recessive autosomal disorder) have
been observed in Calabria, southern Italy [1^3], as well as
numerous genetic variants of both anomalies [4^7].
Studies of the activity of erythrocyte G6PD which were
carried out on carriers of thalassemia (thal trait) and on
thal trait subjects also showing G6PD de¢ciency (G6PD3)
have revealed two fundamental aspects: (a) microcytosis in
subjects with the thal trait causes an increased activity of
G6PD, expressed either as U/g hemoglobin (Hb) or as U/
1012 red blood cells (RBC) [8,9] ; (b) the activity of G6PD
in young erythrocytes is increased [9]; this was con¢rmed by
a study [10], carried out on 20 children a¡ected with transi-
tory erythroblastopenia, in which it was hypothesized that the
activity is 100 times greater in young erythrocytes than in
middle-aged ones. Although the hypothesis of such great ac-
tivity was not con¢rmed by another study [11], performed in
patients showing high reticulocytosis, it has been ascertained
that the G6PD activity in young erythrocytes is undoubtedly
higher.
The aim of the present study was to determine the activity
of G6PD in the following Calabrian sample groups of sub-
jects : normal subjects; thal trait subjects; G6PD3 subjects;
G6PD3+thal trait subjects; G6PD3+total iron serum de¢-
ciency (Fe3) subjects; Fe3 females; and pregnant females.
The clinical and physiological status of the latter two groups
of subjects causes an alteration of their hematological condi-
tion. In order to analyze a statistically valid number of sam-
ples, we adopted the technique of di¡erential pH-metry
[12,13] ; since it uses whole blood, it is able to provide equally
precise results in a shorter time than the method recom-
mended by the World Health Organization [14,15].
2. Materials and methods
The study of G6PD activity was carried out on 1239 samples of
whole blood (anticoagulated with ethylenediaminetetraacetic acid)
from Calabrian subjects of both sexes (age range 10^55): 844 normal
subjects (386 females and 458 males); 127 thal trait (67 females, of
whom 55 L-thal, 7 K1-thal, ‘serious’ K-thalassemia, 5 NL-thal, and 60
males, of whom 50 L-thal, 3 K1-thal and 7 NL-thal); 69 Fe3 females,
of whom 12 were also G6PD3 ; the latter group had mean values of
total iron serum less than 35 Wg/dl; 52 pregnant women (8^32 weeks
of pregnancy); 147 G6PD3 subjects (80 female heterozygotes, G6PD-
heteroz, 17 of whom were thal trait too, and 67 male hemizygotes,
G6PD-hemiz, 16 of whom were thal trait too).
The G6PD-hemiz subjects showing an enzymatic activity at least
5% less than the mean value (9.3 þ 1.0 U/g Hb) of the enzymatic
activity of the normal male subjects were classi¢ed as G6PD Medi-
terranean (G6PD Med) phenotype, while those with values at least 5%
greater than the same mean value of the enzymatic activity of the
normal male subjects were classi¢ed as G6PD non-Mediterranean
(G6PD non-Med). In the carriers of the thalassemia trait, both phe-
notypes were identi¢ed by means of a genetic-familial investigation.
The activity of G6PD was measured by di¡erential pH-metry
[12,13], a technique characterized by simplicity of execution (absence
of any pretreatment of the sample), rapidity of sample analysis
(90 s/analysis), and high reproducibility (within-series CV 3.5%; be-
tween-series CV 2.9%) and accuracy (r = 0.981) [14]. Before the anal-
ysis of the 1239 subjects we excluded 22 (1.8%) because four out of
these 22 (three females and one male) showed a number of platelets
s 400U109/l and 18 (14 females and one male) showed a number of
leukocytes s 12.0U109/l. The subjects described in Tables 1 and 2 do
not include these 22 refused subjects.
Statistical analysis of the results was carried out with Student’s
t-test [16].
3. Results
Before presenting the results, it is necessary to consider two
points : (a) there were no di¡erences in the mean values of
G6PD activity within the subjects with the L, K and NL tha-
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lassemia phenotypes, expressed either as U/g Hb or as U/1012
RBC; therefore, by the term ‘thal trait’ we mean the presence
of any of these thalassemic phenotypes (Tables 1 and 2); (b)
in agreement with other studies [9,14], the enzymatic activity
of G6PD expressed as U/g Hb discriminates the di¡erent
groups of subjects better than the activity expressed per num-
ber of erythrocytes; for this reason, the results that follow
refer to the enzymatic activity expressed as U/g Hb (Table
2). The mean values of main hemometric parameters and total
iron serum of all the groups are reported in Table 1.
The results of erythrocyte G6PD activity determination in
all the subject groups analyzed are reported in Table 2.
The data concerning statistical analysis of di¡erences are
given in Table 3.
As expected, there were signi¢cant di¡erences between the
activity of G6PD of the normal subjects and those with the
thal trait, in both males and females. In fact, the enzymatic
activity of both thal trait groups of subjects was signi¢cantly
increased with respect to the normal subjects. The same was
true in the comparison of normal females with Fe3 females,
because these latter show higher G6PD activity than normal
females. However, the mean enzymatic activity of the latter
group was not far from that of the thal trait females. This
con¢rms the hypothesis [9,10] that the presence of a high
number of young erythrocytes in the circulation, both in the
thal trait subjects and in those with total iron serum de¢-
ciency, masks the true mean value of G6PD activity.
The di¡erence in mean enzymatic activity between the
G6PD-heteroz subjects and the normal females is highly sig-
ni¢cant because the enzymatic activity of the ¢rst group of
subjects is lower than the latter, while the di¡erence between
the latter group and the G6PD-heteroz+thal trait subjects is
at the limit of signi¢cance. The di¡erence between the G6PD-
heteroz+thal trait subjects and the G6PD-heteroz ones is of
greater signi¢cance due to the increase of the enzymatic ac-
tivity of the latter group of subjects. Finally, comparison of
the G6PD-heteroz+thal trait subjects with the thal trait fe-
males reveals the highest discriminant power due to the in-
crease of the enzymatic activity of the latter group of subjects.
The lack of a signi¢cant di¡erence in mean activity between
the G6PD-heteroz+thal trait and G6PD-heteroz+Fe3 groups
con¢rms the role that thalassemia and total iron serum de¢-
ciency play in masking the true enzymatic activity in the fe-
male carriers of the G6PD de¢ciency (Table 3).
When the G6PD-hemiz and G6PD-hemiz+thal trait sub-
jects are compared independently with the normal male sub-
jects and with those with ‘thal trait’, the di¡erences are highly
signi¢cant because both G6PD-hemiz and G6PD-hemiz+thal
trait subjects show a decreased enzymatic activity with respect
to the normal male subjects (Table 3).
The distribution of the values of enzymatic activity of the
G6PD-heteroz and G6PD-heteroz+thal trait subjects indicates
that 76.2% of the ¢rst group and 29.4% of the second are
clearly discriminated from normal females (Fig. 1).
The discrimination of the G6PD-hemiz and the G6PD-hem-
iz+thal trait subjects from the normal ones is 100% (Fig. 2).
The analysis of the male subjects a¡ected with G6PD de¢-
ciency involved the study of the Mediterranean and non-Med-
iterranean phenotypes. The di¡erence between the non-Med
G6PD-hemiz subjects and the non-Med G6PD-hemiz+thal
Table 1
Values of principal hemometric parameters and of total iron serum in the examined groups of subjects
Sample group Sex n Hb (g/dl) RBC (1012/l) Mean corpuscular volume
of erythrocytes (f/l)
Total iron serum
(Wg/dl)
Normals M 458 14.6 þ 1.2 5.1 þ 0.4 83.7 þ 6.5 113 þ 12
F 386 13.4 þ 0.9 4.7 þ 0.4 81.8 þ 7.6 96 þ 10
Pregnant women 52 12.5 þ 0.9 4.2 þ 0.5 86.4 þ 3.5 75 þ 12
Fe3 F 57 9.2 þ 1.4 4.6 þ 0.6 68.6 þ 6.4 21 þ 7
Thal trait M 60 12.0 þ 1.5 6.0 þ 0.5 67.0 þ 5.1 127 þ 16
F 67 10.9 þ 1.7 5.5 þ 0.9 67.4 þ 4.8 112 þ 18
G6PD-hemiz 51 14.1 þ 1.1 4.9 þ 0.4 85.6 þ 4.9 106 þ 11
G6PD-heteroz 63 12.8 þ 1.3 4.4 þ 0.4 86.6 þ 5.3 93 þ 12
G6PD-heteroz+Fe3 12 9.0 þ 1.6 4.4 þ 0.5 66.9 þ 6.0 19 þ 9
G6PD-hemiz+thal trait 16 12.2 þ 1.4 5.9 þ 0.6 85.0 þ 5.1 131 þ 18
G6PD-heteroz+thal trait 17 11.0 þ 1.2 5.3 þ 0.8 85.2 þ 7.0 115 þ 14
Table 2
Mean value þ S.D. and relative values (%) of G6PD activity in whole blood measured by di¡erential pH-metry in the examined groups of sub-
jects
Sample group n Sex G6PD activity
U/g Hb U/1012 RBC
x· þ S.D. % x· þ S.D. %
Normals 458 M 9.3 þ 1.0 100 266 þ 21 100
386 F 9.6 þ 1.0 100 273 þ 23 100
Pregnant women 52 10.0 þ 1.3 104 294 þ 35 107
Fe3 57 W 15.4 þ 4.1 160 305 þ 40 112
Thal trait 60 M 15.3 þ 2.0 164 307 þ 26 115
67 W 16.2 þ 2.3 168 327 þ 43 119
G6PD-hemiz 51 0.7 þ 0.6 8 21 þ 16 8
G6PD-heteroz 63 5.6 þ 1.8 58 163 þ 50 59
G6PD-heteroz+Fe3 12 8.1 þ 1.2 84 165 þ 32 60
G6PD-hemiz+thal trait 16 1.9 þ 1.0 20 40 þ 22 15
G6PD-heteroz+thal trait 17 7.9 þ 2.4 82 165 þ 48 60
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trait ones is at the limit of signi¢cance. In contrast, the di¡er-
ence between the Med G6PD-hemiz subjects and the Med
G6PD-hemiz+thal trait ones is highly signi¢cant because the
latter group shows an increased enzymatic activity (Table 3).
4. Discussion
The Calabrian population has a mean frequency of thalas-
semia trait of 5.2% [1] and of G6PD de¢ciency, referred only
to males, of 1.3% [2,3]. Therefore, the probability of inheriting
both anomalies in the heterozygous form is 0.13% in females
and 0.07% in males.
The results con¢rm the real di⁄culty, already highlighted
by other authors [9], of identifying female heterozygotes for
G6PD de¢ciency when they are also carriers of thalassemia.
This is easily understood when one considers both the role of
random inactivation of the X chromosome [17^19], which per
se renders it impossible to discriminate all heterozygous sub-
jects from normal females, and the role that thalassemia plays
in masking the true values of G6PD activity in these subjects.
In con¢rmation of this, our careful genetic-familial investiga-
tion allowed us to identify the ‘false negative’ heterozygous
carriers and non-carriers of thalassemia whose values of enzy-
matic activity fell within the normal range (Fig. 1); these
subjects were considered ‘obligate’ carriers of the enzyme de-
¢ciency because they were mothers or daughters of a hemi-
zygous subject.
In light of our results, it is clear that in a population like
Fig. 1. Distribution in classes of the values of G6PD activity in: normal females; E heterozygous females; F heterozygous female carriers of
the thalassemia trait.
Table 3
Statistical signi¢cance of the di¡erences in mean values of G6PD activity between the examined groups of subjects by Student’s t-test
Normal F vs. Thal trait F Student’s t = 23.10 P6 0.001
Normal F vs. Fe3 F Student’s t = 10.63 P6 0.001
Thal trait F vs. Fe3 F Student’s t = 1.31 P6 0.2
Normal F vs. G6PD-heteroz Student’s t = 17.26 P6 0.001
Normal F vs. G6PD-heteroz+thal trait Student’s t = 2.91 P6 0.01
G6PD-heteroz vs. G6PD-heteroz+thal trait Student’s t = 3.68 P6 0.001
G6PD-heteroz+thal trait vs. Thal trait F Student’s t = 12.84 P6 0.001
G6PD-heteroz+Fe3 vs. G6PD-heteroz+thal trait Student’s t = 0.54 P6 0.6
Normal F vs. G6PD-heteroz+Fe3 Student’s t = 4.28 P6 0.001
G6PD-heteroz vs. G6PD-heteroz+Fe3 Student’s t = 6.05 P6 0.001
G6PD-heteroz+Fe3 vs. Fe3 W Student’s t = 11.33 P6 0.001
Normal M vs. Thal trait M Student’s t = 22.88 P6 0.001
Normal M vs. G6PD-hemiz Student’s t = 89.40 P6 0.001
Thal trait M vs. G6PD-hemiz Student’s t = 53.80 P6 0.001
Normal M vs. G6PD-hemiz+thal trait Student’s t = 29.10 P6 0.001
Thal trait M vs. G6PD-hemiz+thal trait Student’s t = 37.30 P6 0.001
G6PD-hemiz non-Med vs. G6PD-hemiz non-Med+thal trait Student’s t = 1.92 P = 0.05
G6PD-hemiz Med vs. G6PD-hemiz Med+thal trait Student’s t = 3.91 P6 0.001
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that of Calabria, which presents relatively high frequencies of
both the thalassemia trait and G6PD de¢ciency, the compar-
ison of the G6PD activity of heterozygous subjects also af-
fected with the thalassemia trait is more reliable if performed
with respect to the enzymatic activity of the carriers only for
the latter inherited anomaly rather than with the G6PD ac-
tivity of normal subjects (Table 3). In particular, in carriers of
thalassemia, one must bear in mind the opportunity to distin-
guish those with the K1 phenotype from those with the K2 (or
‘mild’ thalassemia) phenotype. The latter subjects have hemo-
metric values within the normal range; thus they do not show
the thalassemia because they show normal values of G6PD
activity.
Finally, the use of a rapid, precise, reproducible and accu-
rate technique like di¡erential pH-metry [12^14] has not only
allowed us to study a large number of subjects, but has
proved to be an appropriate means of investigation in mass
screening for the identi¢cation of G6PD de¢ciency [2,3].
References
[1] Brancati, C. and Tagarelli, A. (1982) in: Thalassemia: Recent
Advances in Detection and Treatment (Cao, A. and Carcassi,
U., Eds.), Vol. 18, pp. 147^155, Alan R. Liss, New York.
[2] Tagarelli, A., Bastone, L., Cittadella, R., Calabro', V., Bria, M.
and Brancati, C. (1991) Gene Geogr. 5, 141^150.
[3] Tagarelli, A., Cittadella, R., Bria, M. and Brancati, C. (1992)
Gene Geogr. 6, 71^78.
[4] Care', A., Sposi, N.M., Gianpaolo, A., Improta, T., Petrini, M.,
Calandrini, M., Marinucci, M., Tagarelli, A. and Brancati, C.
(1984) J. Med. Genet. 21, 117^120.
[5] Di Rienzo, A., Novelletto, A., Aliquo', M.C., Bianco, I.,
Tagarelli, A., Brancati, C., Colombo, B. and Felicetti, L.
(1986) Am. J. Hum. Genet. 39, 631^639.
[6] Calabro', V., Mason, P.J., Filosa, S., Civitelli, D., Cittadella, R.,
Tagarelli, A., Martini, G., Brancati, C. and Luzzatto, L. (1993)
Am. J. Hum. Genet. 52, 527^536.
[7] Filosa, S., Calabro', V., Lania, G., Vulliamy, T.J., Brancati, C.,
Tagarelli, A., Luzzatto, L. and Martini, G. (1993) Genomics 17,
6^14.
[8] Piomelli, S. and Siniscalco, M. (1969) Br. J. Haematol. 16, 537^
549.
[9] Sanna, G., Frau, F., Melis, M.A., Galanello, R. and DeVirgilis,
S. (1980) Br. J. Haematol. 44, 555^561.
[10] Beutler, E. and Hartman, G. (1985) Pediatr. Res. 19, 44^47.
[11] Staal, G.E. and Rijksen, G. (1991) Adv. Exp. Med. Biol. 307,
239^249.
[12] Barenghi, L., Ceriotti, F., Ripamonti, M., Luzzana, M. and Bo-
nini, P.A. (1987) Clin. Chem. 33, 579^582.
[13] Paleari, R., Ceriotti, F., Bonini, P.A. and Mosca, A. (1990) G.
Ital. Chim. Clin. 15, 191^197.
[14] Mosca, A., Paderi, M., Sanna, A., Paleari, R., Cao, A. and
Galanello, R. (1990) Haematologica 75, 397^399.
[15] Report of a WHO Scienti¢c Group (1967) WHO Technical Re-
port Series 366.
[16] Barrai, I. (1980) Introduzione alla Genetica dei Caratteri Quan-
titativi, Piccin, Padua.
[17] Lyon, M. (1961) Nature 190, 372.
[18] Beutler, E., Yeh, M. and Fairbanks, V.F. (1962) Proc. Natl.
Acad. Sci. USA 48, 9^16.
[19] Beutler, E. (1986) in: X-inactivation in Females Heterozygous for
G6PD Variants, Academic Press, New York.
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